Independent refiner Tesoro
In late October, the MGM Mirage
Tesoro: "No more, though."
Tesoro's board announced last week that it was "neutral" on the tender offer, but it went ahead and instituted a poison-pill defense all the same. This cagey gambit of corporate governance, which has given control investors headaches for 25 years now, would effectively prevent Tracinda from acquiring any more shares. On Monday, Tracinda said that it was "concerned" and "weighing its alternatives."
Tracinda: "We rescind-a!"
Kerkorian and Co. slept on it, and that poison pill didn't taste any better on Tuesday morning, so now the tender is toast. Punters who piled into the stock soon after the initial offer would now be looking at as much as a 25% hit to their holdings.
The speculators got stung, but those of us fortunate enough to be watching from the cheap seats have an interesting opportunity before us. Tesoro is now undeniably cheap.
Some of you like PEG ratios, and Tesoro's is in bargain territory. If, like me, you prefer the enterprise value-to-EBITDA metric, the business is valued at just five times this cash flow proxy. Of course, Valero
For more Texas tea:
Still hungry for more investment knowledge? Get a free trial of any of our newsletters here.